[go: up one dir, main page]

NO20091259L - Metoder for a forsterke hydratisering og slimhinne klarering ved behandling med natrium kanal blokkere og osmolytter - Google Patents

Metoder for a forsterke hydratisering og slimhinne klarering ved behandling med natrium kanal blokkere og osmolytter

Info

Publication number
NO20091259L
NO20091259L NO20091259A NO20091259A NO20091259L NO 20091259 L NO20091259 L NO 20091259L NO 20091259 A NO20091259 A NO 20091259A NO 20091259 A NO20091259 A NO 20091259A NO 20091259 L NO20091259 L NO 20091259L
Authority
NO
Norway
Prior art keywords
treatment
methods
sodium channel
osmolytes
channel blockers
Prior art date
Application number
NO20091259A
Other languages
English (en)
Inventor
Michael R Johnson
Richard C Boucher
Andrew J Hirsch
Original Assignee
Parion Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/077880 external-priority patent/WO2008031028A2/en
Application filed by Parion Sciences Inc filed Critical Parion Sciences Inc
Publication of NO20091259L publication Critical patent/NO20091259L/no

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives metoder og preparater for behandling av sykdommer som lindres ved øket mukociliær klaring og mukosal hydratisering ved administrering av en effektiv mengde natrium kanalblokker som angitt her og en osmolytt, til et individ som trenger øket mukociliær klaring og mukosal hydratisering.
NO20091259A 2006-09-07 2009-03-26 Metoder for a forsterke hydratisering og slimhinne klarering ved behandling med natrium kanal blokkere og osmolytter NO20091259L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84266906P 2006-09-07 2006-09-07
US84517206P 2006-09-18 2006-09-18
PCT/US2007/077880 WO2008031028A2 (en) 2006-09-07 2007-09-07 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes

Publications (1)

Publication Number Publication Date
NO20091259L true NO20091259L (no) 2009-04-17

Family

ID=40786777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091259A NO20091259L (no) 2006-09-07 2009-03-26 Metoder for a forsterke hydratisering og slimhinne klarering ved behandling med natrium kanal blokkere og osmolytter

Country Status (1)

Country Link
NO (1) NO20091259L (no)

Similar Documents

Publication Publication Date Title
MX2009002602A (es) Metodos para aumentar la hidratacion mucosa y el despeje mucoso mediante tratamiento con bloqueadores de canal de sodio y osmolitos.
WO2008031048A3 (en) Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
AR076941A1 (es) Cepa de bacillus para una mayor produccion de proteina
PA8852901A1 (es) Inhibidores de proteina cinasa
MX362375B (es) Extracto de saliva entera de sanguijuela.
EA201100302A1 (ru) Лечение диабета у пациентов, для которых лечение метформином является неприемлемым
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
CR10347A (es) Anticuerpos contra el peptidob-amiloide
MX349027B (es) Uso del fitocannabinoide cannabidiol (cbd) en combinacion con un farmaco estandar antiepileptico (saed) en el tratamiento de la epilepsia.
UY31789A1 (es) Composiciones de insulina de super rápida actuación
PH12015502275A1 (en) Therapuetic uses of empagliflozin
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
BR112015022197A2 (pt) tratamento de cataplexia
EA201491070A1 (ru) Плавучий элемент и способ формирования плавучей системы
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
BR112015008418A2 (pt) uso de uma composição imunogênica, composição imunogênica, e, métodos para intensificar atividade opsônica mediada por anticorpo contra um sorotipo alvejado de streptococcus pneumoniae em um indivíduo e para imunizar um hospedeiro humano contra doenças causadas por infecção por streptococcus pneumoniae
NI201100025A (es) Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos.
BR112014007675A2 (pt) tratamento de doença articular degenerativa
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
CR20110552A (es) Tratamiento de transtornos resistentes a la insulina
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
EA201690323A1 (ru) Способы лечения заболеваний уха у детей
BR112013030068A2 (pt) grânulos de controle biológico estabilizados dispersíveis em água
BRPI0821467B8 (pt) composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application